Methyl-[2-[4-[1-(2-methyl-1,3-benzothiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-5-yl]-oxo-propan-2-ylimino-λ6-sulfane
C22H30N6OS2 — CID 142413936
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl-[2-[4-[1-(2-methyl-1,3-benzothiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-5-yl]-oxo-propan-2-ylimino-λ6-sulfane
Methyl-[2-[4-[1-(2-methyl-1,3-benzothiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-5-yl]-oxo-propan-2-ylimino-λ6-sulfane (PubChem CID 142413936) has the molecular formula C22H30N6OS2 and a molecular weight of 458.66 g/mol. Its IUPAC name is methyl-[2-[4-[1-(2-methyl-1,3-benzothiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-5-yl]-oxo-propan-2-ylimino-λ6-sulfane.
Molecular Properties
| Compound Name | Methyl-[2-[4-[1-(2-methyl-1,3-benzothiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-5-yl]-oxo-propan-2-ylimino-λ6-sulfane |
|---|---|
| PubChem CID | 142413936 |
| Molecular Formula | C22H30N6OS2 |
| Molecular Weight | 458.66 g/mol |
| Exact Mass | 458.19 |
| IUPAC Name | methyl-[2-[4-[1-(2-methyl-1,3-benzothiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-5-yl]-oxo-propan-2-ylimino-λ6-sulfane |
| SMILES | Cc1nc2cc(C(C)N3CCN(c4ncc(S(C)(=O)=NC(C)C)cn4)CC3)ccc2s1 |
| InChI | InChI=1S/C22H30N6OS2/c1-15(2)26-31(5,29)19-13-23-22(24-14-19)28-10-8-27(9-11-28)16(3)18-6-7-21-20(12-18)25-17(4)30-21/h6-7,12-16H,8-11H2,1-5H3 |
| InChIKey | MGIILJHVBLEILM-UHFFFAOYSA-N |
| XLogP | 4.14 |
| TPSA | 74.58 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.66 |
| LogP ≤ 5 | 4.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142413936 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.